References
- van der Hart M, Engelfriet CP, Prins HK, van Loghem H. Haemolytic transfusion reaction without demonstrable anti-bodies in vitro. Vox Sang 1963;8:363–370.
- Hedge UM, Gordon-Smith EC, Worlledge SM. Reticulo-cytopenia and absence of red cell auto antibodies in immune haemolytic anaemia. Br Med J 1977;2:1444–1447.
- Heisto H, Myhre K, Vogt E, Heier AM. Haemolytic transfusion reaction due to incompatibility without demon-strable antibodies. Vox Sang 1960;5:538–544.
- Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction. Transfusion 2001;41: 323–328.
- Win N, Tullie Y, Needs M, Chen FE, Okpala U. Use of intravenous immunoglobulin and intravenous methylpredni-solone in hyperhaemolysis syndrome in sickle cell disease. Haematology 2004;9:433–436.
- Treleaven JG, Win N. Hyperhaemolysis syndrome in a patient with myelofibrosis. Haematology 2004;9:147–149.
- Sokol RJ, Booker DJ, Stamps R, Booth JR, Hook K. IgA red cell autoantibodies and auto-immune hemolysis. Transfusion 1997;37:175–181.
- Lai M, Rumi C, D'onofrio G, Voso MT, Leone G. Clinically significant auto-immune hemolytic anaemia with a negative direct antiglobulin test by routine tube test and positive by column agglutination method. Immunohematology 2002; 18:112.
- Jasinski M, Pantazopoulos P, Rother RP, van Rooijen N, Song WC, Molina H, Bessler M. A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins. Blood 2004; 103(7):2827–2834.
- Packer JT, Greendyke RM, Swisher SN. The inhibition of erythrophagocytosis in vitro by corticosteroids. Transf Assoc Am Physicians 1960;73:93–102.
- Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell haemolytic transfusion reaction syndrome. Transfusion 1997;37:382–392.
- Rhoades CJ, Williams MA, Kelsey SM, Newland AC. Monocyte-macrophage system as targets for immunomodula-tion by intravenous immunoglobulin. Blood Rev 2000; 14:14–30.